All Chip Baird articles
-
NewsBristol Myers Squibb to acquire 2seventy bio
The proposed acquisition, worth nearly $300 million, could help to advance cell therapy in the oncology field.
The proposed acquisition, worth nearly $300 million, could help to advance cell therapy in the oncology field.